Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEVRO PLC Board/Management Information 2020

Apr 29, 2020

4717_mang_2020-04-29_7ca528bd-a835-47d2-8bbd-9488c4516e42.html

Board/Management Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 2355L

Devro PLC

29 April 2020

29 April 2020

DEVRO PLC ("DEVRO" OR THE "COMPANY")

Directorate Appointment

Devro, one of the world's leading manufacturers of collagen products for the food industry, announces the appointment of Jeremy Burks as a Non-Executive Director with effect from 1 May 2020. Jeremy will also become a member of the Audit Committee, the Executive Remuneration Committee and the Nomination Committee from that date.

Jeremy is Executive Vice President at Roquette Group, a privately-owned global leader in plant-based ingredients and a pioneer of new vegetal proteins. He has headed their global commercial function for the last five years and has also driven a global strategic, operational and organisational change programme across the business. Prior to this he spent more than 20 years with Dow Corning in a variety of global business and commercial leadership roles during which time he spent 10 years in Asia establishing and growing specialty businesses in the region.

Nothing in connection with Jeremy's appointment falls to be disclosed under LR 9.6.13.

Steve Good, Devro's Chairman, said:

"I am delighted to welcome Jeremy to Devro's Board of Directors. He brings extensive business leadership experience in international nutrition, health and specialty chemicals businesses and will add skills and insights that will be a valuable addition to support the development and execution of the Company's growth strategy."

ENDS

Contacts:

Devro plc

Rutger Helbing Chief Executive Officer Tel: 020 3865 7637

FTI Consulting

Richard Mountain / Nick Hasell Tel: 020 3727 1340

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

BOAKKFBNCBKDDQB